These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 33540340

  • 1. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.
    Ghofrani HA, Gomez Sanchez MA, Humbert M, Pittrow D, Simonneau G, Gall H, Grünig E, Klose H, Halank M, Langleben D, Snijder RJ, Escribano Subias P, Mielniczuk LM, Lange TJ, Vachiéry JL, Wirtz H, Helmersen DS, Tsangaris I, Barberá JA, Pepke-Zaba J, Boonstra A, Rosenkranz S, Ulrich S, Steringer-Mascherbauer R, Delcroix M, Jansa P, Šimková I, Giannakoulas G, Klotsche J, Williams E, Meier C, Hoeper MM, NEW COLLABORATORS LIST.
    Respir Med; 2021 Mar; 178():106220. PubMed ID: 33540340
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study.
    Halank M, Hoeper MM, Ghofrani HA, Meyer FJ, Stähler G, Behr J, Ewert R, Fletcher M, Colorado P, Nikkho S, Grimminger F.
    Respir Med; 2017 Jul; 128():50-56. PubMed ID: 28610669
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Bishop BM.
    Am J Health Syst Pharm; 2014 Nov 01; 71(21):1839-44. PubMed ID: 25320133
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of riociguat in the treatment of chronic thromboembolic pulmonary arterial hypertension: A meta-analysis.
    Ying M, Song J, Gu S, Zhao R, Li M.
    Medicine (Baltimore); 2021 Jun 04; 100(22):e26211. PubMed ID: 34087896
    [Abstract] [Full Text] [Related]

  • 9. Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial.
    Simonneau G, D'Armini AM, Ghofrani HA, Grimminger F, Jansa P, Kim NH, Mayer E, Pulido T, Wang C, Colorado P, Fritsch A, Meier C, Nikkho S, Hoeper MM.
    Lancet Respir Med; 2016 May 04; 4(5):372-80. PubMed ID: 27067478
    [Abstract] [Full Text] [Related]

  • 10. Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Marra AM, Egenlauf B, Ehlken N, Fischer C, Eichstaedt C, Nagel C, Bossone E, Cittadini A, Halank M, Gall H, Olsson KM, Lange TJ, Grünig E.
    Int J Cardiol; 2015 Sep 15; 195():19-26. PubMed ID: 26011408
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Riociguat for the treatment of pulmonary hypertension.
    Meis T, Behr J.
    Expert Opin Pharmacother; 2014 Nov 15; 15(16):2419-27. PubMed ID: 25260791
    [Abstract] [Full Text] [Related]

  • 14. Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Benza RL, Langleben D, Hemnes AR, Vonk Noordegraaf A, Rosenkranz S, Thenappan T, Hassoun PM, Preston IR, Ghio S, Badagliacca R, Vizza CD, Lang IM, Meier C, Grünig E.
    Eur Respir Rev; 2022 Dec 31; 31(166):. PubMed ID: 36198418
    [Abstract] [Full Text] [Related]

  • 15. Balloon pulmonary angioplasty combined with riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (PRACTICE study): study protocol for a randomized controlled trial.
    Zhao QH, Gong SG, He J, Yuan P, Wu WH, Luo CJ, Jiang R, Zhang R, Qiu HL, Li HT, Li Y, Liu JM, Wang L.
    Trials; 2021 Dec 27; 22(1):957. PubMed ID: 34961562
    [Abstract] [Full Text] [Related]

  • 16. Riociguat: Mode of Action and Clinical Development in Pulmonary Hypertension.
    Ghofrani HA, Humbert M, Langleben D, Schermuly R, Stasch JP, Wilkins MR, Klinger JR.
    Chest; 2017 Feb 27; 151(2):468-480. PubMed ID: 27263466
    [Abstract] [Full Text] [Related]

  • 17. Riociguat: a novel therapeutic option for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Mielniczuk LM, Swiston JR, Mehta S.
    Can J Cardiol; 2014 Oct 27; 30(10):1233-40. PubMed ID: 25154043
    [Abstract] [Full Text] [Related]

  • 18. Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH.
    Gall H, Vachiéry JL, Tanabe N, Halank M, Orozco-Levi M, Mielniczuk L, Chang M, Vogtländer K, Grünig E.
    Lung; 2018 Jun 27; 196(3):305-312. PubMed ID: 29470642
    [Abstract] [Full Text] [Related]

  • 19. Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study.
    Jaïs X, Brenot P, Bouvaist H, Jevnikar M, Canuet M, Chabanne C, Chaouat A, Cottin V, De Groote P, Favrolt N, Horeau-Langlard D, Magro P, Savale L, Prévot G, Renard S, Sitbon O, Parent F, Trésorier R, Tromeur C, Piedvache C, Grimaldi L, Fadel E, Montani D, Humbert M, Simonneau G.
    Lancet Respir Med; 2022 Oct 27; 10(10):961-971. PubMed ID: 35926542
    [Abstract] [Full Text] [Related]

  • 20. Riociguat: a review of its use in patients with chronic thromboembolic pulmonary hypertension or pulmonary arterial hypertension.
    Garnock-Jones KP.
    Drugs; 2014 Nov 27; 74(17):2065-78. PubMed ID: 25352393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.